▶ 調査レポート

世界のヌクレオチド二ナトリウム(I + G)市場 2028年:医薬品用、食品用

• 英文タイトル:Global Disodium Nucleotide (I+G) Market Insights, Forecast to 2028

Global Disodium Nucleotide (I+G) Market Insights, Forecast to 2028「世界のヌクレオチド二ナトリウム(I + G)市場 2028年:医薬品用、食品用」(市場規模、市場予測)調査レポートです。• レポートコード:QY2207C1119
• 出版社/出版日:QYResearch / 2022年7月8日
• レポート形態:英文、PDF、94ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Multi User¥1,087,800 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界のヌクレオチド二ナトリウム(I + G)の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にヌクレオチド二ナトリウム(I + G)の世界市場のxxx%を占める「医薬品用」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「食品」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国のヌクレオチド二ナトリウム(I + G)の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパのヌクレオチド二ナトリウム(I + G)市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのヌクレオチド二ナトリウム(I + G)市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

ヌクレオチド二ナトリウム(I + G)のグローバル主要メーカーには、CJ、Ajinomoto Co., Inc.、MeiHua Holdings Group、Star Lake Bioscience Co., Inc.、Fooding Group Limitedなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

ヌクレオチド二ナトリウム(I + G)市場は、種類と用途によって区分されます。世界のヌクレオチド二ナトリウム(I + G)市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
医薬品用、食品用

【用途別セグメント】
食品、医薬品、工業、生化学、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- ヌクレオチド二ナトリウム(I + G)製品概要
- 種類別市場(医薬品用、食品用)
- 用途別市場(食品、医薬品、工業、生化学、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のヌクレオチド二ナトリウム(I + G)販売量予測2017-2028
- 世界のヌクレオチド二ナトリウム(I + G)売上予測2017-2028
- ヌクレオチド二ナトリウム(I + G)の地域別販売量
- ヌクレオチド二ナトリウム(I + G)の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別ヌクレオチド二ナトリウム(I + G)販売量
- 主要メーカー別ヌクレオチド二ナトリウム(I + G)売上
- 主要メーカー別ヌクレオチド二ナトリウム(I + G)価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(医薬品用、食品用)
- ヌクレオチド二ナトリウム(I + G)の種類別販売量
- ヌクレオチド二ナトリウム(I + G)の種類別売上
- ヌクレオチド二ナトリウム(I + G)の種類別価格
・用途別市場規模(食品、医薬品、工業、生化学、その他)
- ヌクレオチド二ナトリウム(I + G)の用途別販売量
- ヌクレオチド二ナトリウム(I + G)の用途別売上
- ヌクレオチド二ナトリウム(I + G)の用途別価格
・北米市場
- 北米のヌクレオチド二ナトリウム(I + G)市場規模(種類別、用途別)
- 主要国別のヌクレオチド二ナトリウム(I + G)市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのヌクレオチド二ナトリウム(I + G)市場規模(種類別、用途別)
- 主要国別のヌクレオチド二ナトリウム(I + G)市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のヌクレオチド二ナトリウム(I + G)市場規模(種類別、用途別)
- 主要国別のヌクレオチド二ナトリウム(I + G)市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のヌクレオチド二ナトリウム(I + G)市場規模(種類別、用途別)
- 主要国別のヌクレオチド二ナトリウム(I + G)市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのヌクレオチド二ナトリウム(I + G)市場規模(種類別、用途別)
- 主要国別のヌクレオチド二ナトリウム(I + G)市場規模(トルコ、サウジアラビア)
・企業情報
CJ、Ajinomoto Co., Inc.、MeiHua Holdings Group、Star Lake Bioscience Co., Inc.、Fooding Group Limited
・産業チェーン及び販売チャネル分析
- ヌクレオチド二ナトリウム(I + G)の産業チェーン分析
- ヌクレオチド二ナトリウム(I + G)の原材料
- ヌクレオチド二ナトリウム(I + G)の生産プロセス
- ヌクレオチド二ナトリウム(I + G)の販売及びマーケティング
- ヌクレオチド二ナトリウム(I + G)の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- ヌクレオチド二ナトリウム(I + G)の産業動向
- ヌクレオチド二ナトリウム(I + G)のマーケットドライバー
- ヌクレオチド二ナトリウム(I + G)の課題
- ヌクレオチド二ナトリウム(I + G)の阻害要因
・主な調査結果

Market Analysis and Insights: Global Disodium Nucleotide (I+G) Market
Due to the COVID-19 pandemic, the global Disodium Nucleotide (I+G) market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Pharmaceutical Grade accounting for % of the Disodium Nucleotide (I+G) global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Food segment is altered to an % CAGR throughout this forecast period.
China Disodium Nucleotide (I+G) market size is valued at US$ million in 2021, while the US and Europe Disodium Nucleotide (I+G) are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Disodium Nucleotide (I+G) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Disodium Nucleotide (I+G) include CJ, Ajinomoto Co., Inc., MeiHua Holdings Group, Star Lake Bioscience Co., Inc. and Fooding Group Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
In terms of production side, this report researches the Disodium Nucleotide (I+G) capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Disodium Nucleotide (I+G) by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Global Disodium Nucleotide (I+G) Scope and Segment
Disodium Nucleotide (I+G) market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Disodium Nucleotide (I+G) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Pharmaceutical Grade
Food Grade
Segment by Application
Food
Pharmaceutical
Industry
Daily Chemical
Others
By Company
CJ
Ajinomoto Co., Inc.
MeiHua Holdings Group
Star Lake Bioscience Co., Inc.
Fooding Group Limited
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Disodium Nucleotide (I+G) Product Introduction
1.2 Market by Type
1.2.1 Global Disodium Nucleotide (I+G) Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Pharmaceutical Grade
1.2.3 Food Grade
1.3 Market by Application
1.3.1 Global Disodium Nucleotide (I+G) Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Food
1.3.3 Pharmaceutical
1.3.4 Industry
1.3.5 Daily Chemical
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Disodium Nucleotide (I+G) Production
2.1 Global Disodium Nucleotide (I+G) Production Capacity (2017-2028)
2.2 Global Disodium Nucleotide (I+G) Production by Region: 2017 VS 2021 VS 2028
2.3 Global Disodium Nucleotide (I+G) Production by Region
2.3.1 Global Disodium Nucleotide (I+G) Historic Production by Region (2017-2022)
2.3.2 Global Disodium Nucleotide (I+G) Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Disodium Nucleotide (I+G) Sales in Volume & Value Estimates and Forecasts
3.1 Global Disodium Nucleotide (I+G) Sales Estimates and Forecasts 2017-2028
3.2 Global Disodium Nucleotide (I+G) Revenue Estimates and Forecasts 2017-2028
3.3 Global Disodium Nucleotide (I+G) Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Disodium Nucleotide (I+G) Sales by Region
3.4.1 Global Disodium Nucleotide (I+G) Sales by Region (2017-2022)
3.4.2 Global Sales Disodium Nucleotide (I+G) by Region (2023-2028)
3.5 Global Disodium Nucleotide (I+G) Revenue by Region
3.5.1 Global Disodium Nucleotide (I+G) Revenue by Region (2017-2022)
3.5.2 Global Disodium Nucleotide (I+G) Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Disodium Nucleotide (I+G) Production Capacity by Manufacturers
4.2 Global Disodium Nucleotide (I+G) Sales by Manufacturers
4.2.1 Global Disodium Nucleotide (I+G) Sales by Manufacturers (2017-2022)
4.2.2 Global Disodium Nucleotide (I+G) Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Disodium Nucleotide (I+G) in 2021
4.3 Global Disodium Nucleotide (I+G) Revenue by Manufacturers
4.3.1 Global Disodium Nucleotide (I+G) Revenue by Manufacturers (2017-2022)
4.3.2 Global Disodium Nucleotide (I+G) Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Disodium Nucleotide (I+G) Revenue in 2021
4.4 Global Disodium Nucleotide (I+G) Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Disodium Nucleotide (I+G) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Disodium Nucleotide (I+G) Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Disodium Nucleotide (I+G) Sales by Type
5.1.1 Global Disodium Nucleotide (I+G) Historical Sales by Type (2017-2022)
5.1.2 Global Disodium Nucleotide (I+G) Forecasted Sales by Type (2023-2028)
5.1.3 Global Disodium Nucleotide (I+G) Sales Market Share by Type (2017-2028)
5.2 Global Disodium Nucleotide (I+G) Revenue by Type
5.2.1 Global Disodium Nucleotide (I+G) Historical Revenue by Type (2017-2022)
5.2.2 Global Disodium Nucleotide (I+G) Forecasted Revenue by Type (2023-2028)
5.2.3 Global Disodium Nucleotide (I+G) Revenue Market Share by Type (2017-2028)
5.3 Global Disodium Nucleotide (I+G) Price by Type
5.3.1 Global Disodium Nucleotide (I+G) Price by Type (2017-2022)
5.3.2 Global Disodium Nucleotide (I+G) Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Disodium Nucleotide (I+G) Sales by Application
6.1.1 Global Disodium Nucleotide (I+G) Historical Sales by Application (2017-2022)
6.1.2 Global Disodium Nucleotide (I+G) Forecasted Sales by Application (2023-2028)
6.1.3 Global Disodium Nucleotide (I+G) Sales Market Share by Application (2017-2028)
6.2 Global Disodium Nucleotide (I+G) Revenue by Application
6.2.1 Global Disodium Nucleotide (I+G) Historical Revenue by Application (2017-2022)
6.2.2 Global Disodium Nucleotide (I+G) Forecasted Revenue by Application (2023-2028)
6.2.3 Global Disodium Nucleotide (I+G) Revenue Market Share by Application (2017-2028)
6.3 Global Disodium Nucleotide (I+G) Price by Application
6.3.1 Global Disodium Nucleotide (I+G) Price by Application (2017-2022)
6.3.2 Global Disodium Nucleotide (I+G) Price Forecast by Application (2023-2028)
7 North America
7.1 North America Disodium Nucleotide (I+G) Market Size by Type
7.1.1 North America Disodium Nucleotide (I+G) Sales by Type (2017-2028)
7.1.2 North America Disodium Nucleotide (I+G) Revenue by Type (2017-2028)
7.2 North America Disodium Nucleotide (I+G) Market Size by Application
7.2.1 North America Disodium Nucleotide (I+G) Sales by Application (2017-2028)
7.2.2 North America Disodium Nucleotide (I+G) Revenue by Application (2017-2028)
7.3 North America Disodium Nucleotide (I+G) Sales by Country
7.3.1 North America Disodium Nucleotide (I+G) Sales by Country (2017-2028)
7.3.2 North America Disodium Nucleotide (I+G) Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Disodium Nucleotide (I+G) Market Size by Type
8.1.1 Europe Disodium Nucleotide (I+G) Sales by Type (2017-2028)
8.1.2 Europe Disodium Nucleotide (I+G) Revenue by Type (2017-2028)
8.2 Europe Disodium Nucleotide (I+G) Market Size by Application
8.2.1 Europe Disodium Nucleotide (I+G) Sales by Application (2017-2028)
8.2.2 Europe Disodium Nucleotide (I+G) Revenue by Application (2017-2028)
8.3 Europe Disodium Nucleotide (I+G) Sales by Country
8.3.1 Europe Disodium Nucleotide (I+G) Sales by Country (2017-2028)
8.3.2 Europe Disodium Nucleotide (I+G) Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Disodium Nucleotide (I+G) Market Size by Type
9.1.1 Asia Pacific Disodium Nucleotide (I+G) Sales by Type (2017-2028)
9.1.2 Asia Pacific Disodium Nucleotide (I+G) Revenue by Type (2017-2028)
9.2 Asia Pacific Disodium Nucleotide (I+G) Market Size by Application
9.2.1 Asia Pacific Disodium Nucleotide (I+G) Sales by Application (2017-2028)
9.2.2 Asia Pacific Disodium Nucleotide (I+G) Revenue by Application (2017-2028)
9.3 Asia Pacific Disodium Nucleotide (I+G) Sales by Region
9.3.1 Asia Pacific Disodium Nucleotide (I+G) Sales by Region (2017-2028)
9.3.2 Asia Pacific Disodium Nucleotide (I+G) Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Disodium Nucleotide (I+G) Market Size by Type
10.1.1 Latin America Disodium Nucleotide (I+G) Sales by Type (2017-2028)
10.1.2 Latin America Disodium Nucleotide (I+G) Revenue by Type (2017-2028)
10.2 Latin America Disodium Nucleotide (I+G) Market Size by Application
10.2.1 Latin America Disodium Nucleotide (I+G) Sales by Application (2017-2028)
10.2.2 Latin America Disodium Nucleotide (I+G) Revenue by Application (2017-2028)
10.3 Latin America Disodium Nucleotide (I+G) Sales by Country
10.3.1 Latin America Disodium Nucleotide (I+G) Sales by Country (2017-2028)
10.3.2 Latin America Disodium Nucleotide (I+G) Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
10.3.6 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Disodium Nucleotide (I+G) Market Size by Type
11.1.1 Middle East and Africa Disodium Nucleotide (I+G) Sales by Type (2017-2028)
11.1.2 Middle East and Africa Disodium Nucleotide (I+G) Revenue by Type (2017-2028)
11.2 Middle East and Africa Disodium Nucleotide (I+G) Market Size by Application
11.2.1 Middle East and Africa Disodium Nucleotide (I+G) Sales by Application (2017-2028)
11.2.2 Middle East and Africa Disodium Nucleotide (I+G) Revenue by Application (2017-2028)
11.3 Middle East and Africa Disodium Nucleotide (I+G) Sales by Country
11.3.1 Middle East and Africa Disodium Nucleotide (I+G) Sales by Country (2017-2028)
11.3.2 Middle East and Africa Disodium Nucleotide (I+G) Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 CJ
12.1.1 CJ Corporation Information
12.1.2 CJ Overview
12.1.3 CJ Disodium Nucleotide (I+G) Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 CJ Disodium Nucleotide (I+G) Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 CJ Recent Developments
12.2 Ajinomoto Co., Inc.
12.2.1 Ajinomoto Co., Inc. Corporation Information
12.2.2 Ajinomoto Co., Inc. Overview
12.2.3 Ajinomoto Co., Inc. Disodium Nucleotide (I+G) Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Ajinomoto Co., Inc. Disodium Nucleotide (I+G) Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Ajinomoto Co., Inc. Recent Developments
12.3 MeiHua Holdings Group
12.3.1 MeiHua Holdings Group Corporation Information
12.3.2 MeiHua Holdings Group Overview
12.3.3 MeiHua Holdings Group Disodium Nucleotide (I+G) Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 MeiHua Holdings Group Disodium Nucleotide (I+G) Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 MeiHua Holdings Group Recent Developments
12.4 Star Lake Bioscience Co., Inc.
12.4.1 Star Lake Bioscience Co., Inc. Corporation Information
12.4.2 Star Lake Bioscience Co., Inc. Overview
12.4.3 Star Lake Bioscience Co., Inc. Disodium Nucleotide (I+G) Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Star Lake Bioscience Co., Inc. Disodium Nucleotide (I+G) Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Star Lake Bioscience Co., Inc. Recent Developments
12.5 Fooding Group Limited
12.5.1 Fooding Group Limited Corporation Information
12.5.2 Fooding Group Limited Overview
12.5.3 Fooding Group Limited Disodium Nucleotide (I+G) Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Fooding Group Limited Disodium Nucleotide (I+G) Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Fooding Group Limited Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Disodium Nucleotide (I+G) Industry Chain Analysis
13.2 Disodium Nucleotide (I+G) Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Disodium Nucleotide (I+G) Production Mode & Process
13.4 Disodium Nucleotide (I+G) Sales and Marketing
13.4.1 Disodium Nucleotide (I+G) Sales Channels
13.4.2 Disodium Nucleotide (I+G) Distributors
13.5 Disodium Nucleotide (I+G) Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Disodium Nucleotide (I+G) Industry Trends
14.2 Disodium Nucleotide (I+G) Market Drivers
14.3 Disodium Nucleotide (I+G) Market Challenges
14.4 Disodium Nucleotide (I+G) Market Restraints
15 Key Finding in The Global Disodium Nucleotide (I+G) Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer